BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 26648189)

  • 21. Single molecule force spectroscopy for in-situ probing oridonin inhibited ROS-mediated EGF-EGFR interactions in living KYSE-150 cells.
    Pi J; Jin H; Jiang J; Yang F; Cai H; Yang P; Cai J; Chen ZW
    Pharmacol Res; 2017 May; 119():479-489. PubMed ID: 28411855
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Jaridonin, a novel ent-kaurene diterpenoid from Isodon rubescens, inducing apoptosis via production of reactive oxygen species in esophageal cancer cells.
    Ma YC; Ke Y; Zi X; Zhao W; Shi XJ; Liu HM
    Curr Cancer Drug Targets; 2013 Jul; 13(6):611-24. PubMed ID: 23597192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oridonin Suppresses Proliferation of Human Ovarian Cancer Cells via Blockage of mTOR Signaling.
    Xia R; Chen SX; Qin Q; Chen Y; Zhang WW; Zhu RR; Deng AM
    Asian Pac J Cancer Prev; 2016; 17(2):667-71. PubMed ID: 26925661
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Mechanism of downregulation of apoptosis by autophagy induced by oridonin in HeLa cells].
    Cui Q; Tashiro S; Onodera S; Ikejima T
    Yao Xue Xue Bao; 2007 Jan; 42(1):35-9. PubMed ID: 17520804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of oridonin on apoptosis and intracellular reactive oxygen species level in triple-negative breast cancer MDA-MB-231 cells].
    Qi Q; Zhang P; Li QX; Pan Q; Zheng HL; Zhao SR
    Zhongguo Zhong Yao Za Zhi; 2017 Jun; 42(12):2361-2365. PubMed ID: 28822194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oridonin induces growth inhibition and apoptosis in human gastric carcinoma cells by enhancement of p53 expression and function.
    Bi E; Liu D; Li Y; Mao X; Wang A; Wang J
    Braz J Med Biol Res; 2018 Nov; 51(12):e7599. PubMed ID: 30462771
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined oridonin with cetuximab treatment shows synergistic anticancer effects on laryngeal squamous cell carcinoma: involvement of inhibition of EGFR and activation of reactive oxygen species-mediated JNK pathway.
    Cao S; Xia M; Mao Y; Zhang Q; Donkor PO; Qiu F; Kang N
    Int J Oncol; 2016 Nov; 49(5):2075-2087. PubMed ID: 27667173
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autophagy counteracts apoptosis in human multiple myeloma cells exposed to oridonin in vitro via regulating intracellular ROS and SIRT1.
    Zeng R; Chen Y; Zhao S; Cui GH
    Acta Pharmacol Sin; 2012 Jan; 33(1):91-100. PubMed ID: 22158107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel combination of oridonin and valproic acid in enhancement of apoptosis induction of HL-60 leukemia cells.
    Shi M; Ren X; Wang X; Wang H; Liu G; Yuan X; Zheng S; Yu L; Pan S; Song G; Guo Q; Li L; Zhang X; Zhang Z; Ding H; Jiang G
    Int J Oncol; 2016 Feb; 48(2):734-46. PubMed ID: 26676928
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oridonin induces NPM mutant protein translocation and apoptosis in NPM1c+ acute myeloid leukemia cells in vitro.
    Li FF; Yi S; Wen L; He J; Yang LJ; Zhao J; Zhang BP; Cui GH; Chen Y
    Acta Pharmacol Sin; 2014 Jun; 35(6):806-13. PubMed ID: 24902788
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oridonin: targeting programmed cell death pathways as an anti-tumour agent.
    Liu Z; Ouyang L; Peng H; Zhang WZ
    Cell Prolif; 2012 Dec; 45(6):499-507. PubMed ID: 23106297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oridonin induces apoptosis via PI3K/Akt pathway in cervical carcinoma HeLa cell line.
    Hu HZ; Yang YB; Xu XD; Shen HW; Shu YM; Ren Z; Li XM; Shen HM; Zeng HT
    Acta Pharmacol Sin; 2007 Nov; 28(11):1819-26. PubMed ID: 17959034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular mechanisms of apoptosis and autophagy elicited by combined treatment with oridonin and cetuximab in laryngeal squamous cell carcinoma.
    Cao S; Huang Y; Zhang Q; Lu F; Donkor PO; Zhu Y; Qiu F; Kang N
    Apoptosis; 2019 Feb; 24(1-2):33-45. PubMed ID: 30430397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antitumor and Antibacterial Derivatives of Oridonin: A Main Composition of Dong-Ling-Cao.
    Li D; Han T; Xu S; Zhou T; Tian K; Hu X; Cheng K; Li Z; Hua H; Xu J
    Molecules; 2016 Apr; 21(5):. PubMed ID: 27144553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The anticancer effect of oridonin is mediated by fatty acid synthase suppression in human colorectal cancer cells.
    Kwan HY; Yang Z; Fong WF; Hu YM; Yu ZL; Hsiao WL
    J Gastroenterol; 2013 Feb; 48(2):182-92. PubMed ID: 22722903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cetuximab enhances oridonin-induced apoptosis through mitochondrial pathway and endoplasmic reticulum stress in laryngeal squamous cell carcinoma cells.
    Kang N; Cao S; Jiang B; Zhang Q; Donkor PO; Zhu Y; Qiu F; Gao X
    Toxicol In Vitro; 2020 Sep; 67():104885. PubMed ID: 32407876
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The cytostatic and cytotoxic effects of oridonin (Rubescenin), a diterpenoid from Rabdosia rubescens, on tumor cells of different lineage.
    Chen S; Gao J; Halicka HD; Huang X; Traganos F; Darzynkiewicz Z
    Int J Oncol; 2005 Mar; 26(3):579-88. PubMed ID: 15703811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential control of growth, cell cycle progression, and expression of NF-kappaB in human breast cancer cells MCF-7, MCF-10A, and MDA-MB-231 by ponicidin and oridonin, diterpenoids from the chinese herb Rabdosia rubescens.
    Hsieh TC; Wijeratne EK; Liang JY; Gunatilaka AL; Wu JM
    Biochem Biophys Res Commun; 2005 Nov; 337(1):224-31. PubMed ID: 16176802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiproliferation effects of oridonin on HPB-ALL cells and its mechanisms of action.
    Liu JJ; Huang RW; Lin DJ; Wu XY; Peng J; Pan XL; Lin Q; Hou M; Zhang MH; Chen F
    Am J Hematol; 2006 Feb; 81(2):86-94. PubMed ID: 16432862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inactivation of ras and changes of mitochondrial membrane potential contribute to oridonin-induced autophagy in a431 cells.
    Li D; Cui Q; Chen SG; Wu LJ; Tashiro S; Onodera S; Ikejima T
    J Pharmacol Sci; 2007 Sep; 105(1):22-33. PubMed ID: 17895587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.